116 related articles for article (PubMed ID: 30911995)
1. Attenuation of MAMLD1 Expression Suppresses the Growth and Migratory Properties of Gonadotroph Pituitary Adenomas.
Qi J; Ni W
Pathol Oncol Res; 2020 Apr; 26(2):937-946. PubMed ID: 30911995
[TBL] [Abstract][Full Text] [Related]
2. Mastermind-like domain-containing 1 (MAMLD1 or CXorf6) transactivates the Hes3 promoter, augments testosterone production, and contains the SF1 target sequence.
Fukami M; Wada Y; Okada M; Kato F; Katsumata N; Baba T; Morohashi K; Laporte J; Kitagawa M; Ogata T
J Biol Chem; 2008 Feb; 283(9):5525-32. PubMed ID: 18162467
[TBL] [Abstract][Full Text] [Related]
3. Lineage-specific restraint of pituitary gonadotroph cell adenoma growth.
Chesnokova V; Zonis S; Zhou C; Ben-Shlomo A; Wawrowsky K; Toledano Y; Tong Y; Kovacs K; Scheithauer B; Melmed S
PLoS One; 2011 Mar; 6(3):e17924. PubMed ID: 21464964
[TBL] [Abstract][Full Text] [Related]
4. Transcriptome analysis of MENX-associated rat pituitary adenomas identifies novel molecular mechanisms involved in the pathogenesis of human pituitary gonadotroph adenomas.
Lee M; Marinoni I; Irmler M; Psaras T; Honegger JB; Beschorner R; Anastasov N; Beckers J; Theodoropoulou M; Roncaroli F; Pellegata NS
Acta Neuropathol; 2013 Jul; 126(1):137-50. PubMed ID: 23756599
[TBL] [Abstract][Full Text] [Related]
5. MAMLD1 (CXorf6): a new gene involved in hypospadias.
Ogata T; Laporte J; Fukami M
Horm Res; 2009; 71(5):245-52. PubMed ID: 19339788
[TBL] [Abstract][Full Text] [Related]
6. Folate receptor alpha regulates cell proliferation in mouse gonadotroph alphaT3-1 cells.
Yao C; Evans CO; Stevens VL; Owens TR; Oyesiku NM
Exp Cell Res; 2009 Nov; 315(18):3125-32. PubMed ID: 19446551
[TBL] [Abstract][Full Text] [Related]
7. The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph.
Asa SL; Bamberger AM; Cao B; Wong M; Parker KL; Ezzat S
J Clin Endocrinol Metab; 1996 Jun; 81(6):2165-70. PubMed ID: 8964846
[TBL] [Abstract][Full Text] [Related]
8. ADAM12 induces EMT and promotes cell migration, invasion and proliferation in pituitary adenomas via EGFR/ERK signaling pathway.
Wang J; Zhang Z; Li R; Mao F; Sun W; Chen J; Zhang H; Bartsch JW; Shu K; Lei T
Biomed Pharmacother; 2018 Jan; 97():1066-1077. PubMed ID: 29136943
[TBL] [Abstract][Full Text] [Related]
9. Gonadotroph adenoma with secondary hypersecretion of testosterone.
Chamoun R; Layfield L; Couldwell WT
World Neurosurg; 2013 Dec; 80(6):900.e7-11. PubMed ID: 23201183
[TBL] [Abstract][Full Text] [Related]
10. MAMLD1 and 46,XY disorders of sex development.
Ogata T; Sano S; Nagata E; Kato F; Fukami M
Semin Reprod Med; 2012 Oct; 30(5):410-6. PubMed ID: 23044878
[TBL] [Abstract][Full Text] [Related]
11. MAMLD1 (CXorf6): a new gene for hypospadias.
Ogata T; Wada Y; Fukami M
Sex Dev; 2008; 2(4-5):244-50. PubMed ID: 18987498
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of PITX2 transcription factor induced apoptosis of gonadotroph tumoral cells.
Acunzo J; Roche C; Defilles C; Thirion S; Quentien MH; Figarella-Branger D; Graillon T; Dufour H; Brue T; Pellegrini I; Enjalbert A; Barlier A
Endocrinology; 2011 Oct; 152(10):3884-92. PubMed ID: 21810944
[TBL] [Abstract][Full Text] [Related]
13. PPAR-gamma receptor ligands: novel therapy for pituitary adenomas.
Heaney AP; Fernando M; Melmed S
J Clin Invest; 2003 May; 111(9):1381-8. PubMed ID: 12727930
[TBL] [Abstract][Full Text] [Related]
14. Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile.
Batista RL; Trarbach EB; Marques MD; Cescato VA; da Silva GO; Herkenhoff CGB; Cunha-Neto MB; Musolino NR
World Neurosurg; 2018 Dec; 120():e241-e246. PubMed ID: 30138730
[TBL] [Abstract][Full Text] [Related]
15. Disorders of Sex Development in Individuals Harbouring
Li L; Gao F; Fan L; Su C; Liang X; Gong C
Front Endocrinol (Lausanne); 2020; 11():582516. PubMed ID: 33424767
[TBL] [Abstract][Full Text] [Related]
16. Immune Landscape of Pituitary Tumors Reveals Association Between Macrophages and Gonadotroph Tumor Invasion.
Principe M; Chanal M; Ilie MD; Ziverec A; Vasiljevic A; Jouanneau E; Hennino A; Raverot G; Bertolino P
J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32785693
[TBL] [Abstract][Full Text] [Related]
17. The role of proto-oncogene GLI1 in pituitary adenoma formation and cell survival regulation.
Lampichler K; Ferrer P; Vila G; Lutz MI; Wolf F; Knosp E; Wagner L; Luger A; Baumgartner-Parzer S
Endocr Relat Cancer; 2015 Oct; 22(5):793-803. PubMed ID: 26219678
[TBL] [Abstract][Full Text] [Related]
18. Galectin-3 expression in pituitary adenomas as a marker of aggressive behavior.
Righi A; Morandi L; Leonardi E; Farnedi A; Marucci G; Sisto A; Frank G; Faustini-Fustini M; Zoli M; Mazzatenta D; Agati R; Foschini MP
Hum Pathol; 2013 Nov; 44(11):2400-9. PubMed ID: 24007691
[TBL] [Abstract][Full Text] [Related]
19. A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression.
Chen H; Hu L; Luo Z; Zhang J; Zhang C; Qiu B; Dong L; Tan Y; Ding J; Tang S; Shen F; Li Z; Wang H
Mol Cancer; 2015 Nov; 14():186. PubMed ID: 26538215
[TBL] [Abstract][Full Text] [Related]
20. MAMLD1 and Differences/Disorders of Sex Development: An Update.
Miyado M; Fukami M; Ogata T
Sex Dev; 2022; 16(2-3):126-137. PubMed ID: 34695834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
